Quest Diagnostics Operating Margin 2010-2024 | DGX

Current and historical operating margin for Quest Diagnostics (DGX) over the last 10 years. The current operating profit margin for Quest Diagnostics as of March 31, 2024 is 10.68%.
Quest Diagnostics Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $9.29B $1.26B 13.54%
2023-12-31 $9.25B $1.26B 13.64%
2023-09-30 $9.30B $1.13B 12.15%
2023-06-30 $9.49B $1.18B 12.44%
2023-03-31 $9.60B $1.22B 12.70%
2022-12-31 $9.88B $1.43B 14.45%
2022-09-30 $10.29B $1.83B 17.77%
2022-06-30 $10.58B $2.09B 19.74%
2022-03-31 $10.68B $2.23B 20.92%
2021-12-31 $10.79B $2.38B 22.07%
2021-09-30 $11.05B $2.64B 23.90%
2021-06-30 $11.06B $2.71B 24.47%
2021-03-31 $10.34B $2.46B 23.76%
2020-12-31 $9.44B $1.97B 20.89%
2020-09-30 $8.36B $1.54B 18.41%
2020-06-30 $7.53B $1.13B 15.06%
2020-03-31 $7.66B $1.16B 15.12%
2019-12-31 $7.73B $1.23B 15.93%
2019-09-30 $7.64B $1.09B 14.24%
2019-06-30 $7.57B $1.08B 14.25%
2019-03-31 $7.54B $1.08B 14.29%
2018-12-31 $7.53B $1.10B 14.62%
2018-09-30 $7.56B $1.15B 15.22%
2018-06-30 $7.52B $1.14B 15.20%
2018-03-31 $7.47B $1.16B 15.50%
2017-12-31 $7.40B $1.17B 15.74%
2017-09-30 $7.10B $1.17B 16.51%
2017-06-30 $7.13B $1.20B 16.78%
2017-03-31 $7.17B $1.30B 18.12%
2016-12-31 $7.21B $1.28B 17.70%
2016-09-30 $7.50B $1.24B 16.53%
2016-06-30 $7.50B $1.55B 20.66%
2016-03-31 $7.52B $1.43B 19.00%
2015-12-31 $7.49B $1.40B 18.67%
2015-09-30 $7.53B $1.42B 18.83%
2015-06-30 $7.55B $1.04B 13.80%
2015-03-31 $7.53B $1.00B 13.32%
2014-12-31 $7.44B $0.98B 13.22%
2014-09-30 $7.31B $1.00B 13.63%
2014-06-30 $7.19B $1.43B 19.87%
2014-03-31 $7.11B $1.46B 20.49%
2013-12-31 $7.15B $1.48B 20.64%
2013-09-30 $7.16B $1.47B 20.52%
2013-06-30 $7.20B $1.09B 15.09%
2013-03-31 $7.26B $1.13B 15.56%
2012-12-31 $7.38B $1.20B 16.27%
2012-09-30 $7.37B $1.25B 17.00%
2012-06-30 $7.45B $1.27B 17.04%
2012-03-31 $7.48B $1.25B 16.77%
2011-12-31 $7.39B $0.99B 13.35%
2011-09-30 $7.35B $0.95B 12.96%
2011-06-30 $7.31B $0.97B 13.24%
2011-03-31 $7.28B $1.02B 13.96%
2010-12-31 $7.26B $1.28B 17.68%
2010-09-30 $7.39B $1.33B 18.01%
2010-06-30 $7.43B $1.34B 18.09%
2010-03-31 $7.45B $1.34B 17.93%
2009-12-31 $7.46B $1.36B 18.22%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.759B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
Amedisys (AMED) United States $3.162B 22.40
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00